Characterization of Candida albicans microtubules
白色念珠菌微管的表征
基本信息
- 批准号:6540835
- 负责人:
- 金额:$ 3.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-15 至 2004-04-30
- 项目状态:已结题
- 来源:
- 关键词:Candida albicans SDS polyacrylamide gel electrophoresis Saccharomyces cerevisiae antifungal agents binding sites colchicine conformation crosslink drug interactions fungal proteins guanosine diphosphate guanosine triphosphate method development microtubule associated protein microtubules molecular dynamics nerve /myelin protein phosphorylation polymerization protein purification protein structure radiotracer spirane tau proteins tubulin
项目摘要
DESCRIPTION
Candida albicans, an opportunistic pathogen, can cause vaginal, oral and lung
infections in immunocompromised individuals and systemic tissue damages in
acquired immunodeficiency patients. The chemotherapy of C. albicans infections
is limited because of the strong similarities between C. albicans cells and
human cells. However, the mitotic spindles in mammalian and Candida cells are
constructed differently. In addition, significant differences exist in the
sequences of fungal and mammalian tubulins, which are the building block units
of mitotic spindles. Little information is available at biochemical and
functional levels about Candida tubulin, and virtually nothing is known
regarding the polymerization and dynamics properties of Candida microtubules.
The thinking is that understanding the differences between fungal cell tubulin
and mammalian tubulin could lead to development of new and selective drugs for
the treatment of fungal diseases. Therefore, it is proposed to develop a
large-scale purification strategy for C. Albicans tubulin based upon previous
success in this laboratory with tubulin from Saccharomyces cerevisiae. The
tubulin will be characterized biochemically, and the polymerization and dynamic
properties of Candida microtubules determined. Finally, the mechanism of
interaction of two known microtubule-targeted antifungal drugs (benomyl and
griseofulvin) with the Candida tubulin will be determined and the mechanisms by
which the drugs modulate the polymerization and dynamics properties of the
tubulin will be elucidated.
描述
白色念珠菌是一种条件致病菌,可引起阴道,口腔和肺部
免疫功能低下个体的感染和
获得性免疫缺陷患者。C.白色念珠菌感染
由于C.白色念珠菌细胞和
人类细胞。然而,哺乳动物和念珠菌属细胞中的有丝分裂纺锤体是
构造不同。此外,在这些方面也存在显著差异。
真菌和哺乳动物微管蛋白的序列,它们是构建单元
有丝分裂纺锤体在生物化学和
关于念珠菌微管蛋白的功能水平,几乎一无所知
关于念珠菌微管的聚合和动力学性质。
这个想法是,了解真菌细胞微管蛋白之间的差异,
和哺乳动物微管蛋白可能导致开发新的和选择性的药物,
真菌疾病的治疗因此,建议开发一个
大规模纯化C. Albicans微管蛋白基于先前的
在这个实验室中成功地从酿酒酵母微管蛋白。的
将对微管蛋白进行生物化学表征,并对其聚合和动态进行表征
确定念珠菌微管的性质。最后,
两种已知微管靶向抗真菌药物(苯菌灵和
灰黄霉素)与念珠菌微管蛋白将被确定和机制,
其中药物调节聚合和动力学性质,
将阐明微管蛋白。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESLIE WILSON其他文献
LESLIE WILSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESLIE WILSON', 18)}}的其他基金
DRUG INTERACTIONS WITH BRAIN MICROTUBULE PROTEINS
药物与脑微管蛋白的相互作用
- 批准号:
3395259 - 财政年份:1978
- 资助金额:
$ 3.86万 - 项目类别:
DRUG INTERACTIONS WITH BRAIN MICROTUBULE PROTEINS
药物与脑微管蛋白的相互作用
- 批准号:
3395257 - 财政年份:1978
- 资助金额:
$ 3.86万 - 项目类别:
Mechanism and Control of Brain Microtubule Dynamics
脑微管动力学的机制和控制
- 批准号:
7615580 - 财政年份:1978
- 资助金额:
$ 3.86万 - 项目类别:
MECHANISM AND CONTROL OF BRAIN MICROTUBULE DYNAMICS
脑微管动力学机制及控制
- 批准号:
2431113 - 财政年份:1978
- 资助金额:
$ 3.86万 - 项目类别: